ARID1A Antibody, Rabbit PAb

Catalog number: HPA005456
Brand: Atlas Antibodies
Packing: 100 ul
Price: € 327.00
Expected delivery time: 7 days
Quantity:

Product specifications for - ARID1A Antibody, Rabbit PAb

Overview: 
Product group: Antibodies
Category: Primary Antibodies
Application: ImmunoFluorescence, ImmunoHistoChemistry
Host: Rabbit
Target: ARID1A
Target description: AT rich interactive domain 1A (SWI-like)
Clonality: Polyclonal
Isotype: IgG
Properties: 
Purity: Purification method: Affinity purified using the PrEST antigen as affinity ligand
Datasheet: Datasheet
  Research Use Only
UNSPSC: 12352203
Form supplied: The antibodies are delivered in 40% glycerol and PBS (pH 7.2). 0.02% sodium azide is added as preservative.
Storage instructions: Store at +4°C for short term storage. Long time storage is recommended at -20°C.
Scientific information: 
Scientific info: Specification: This antibody has been used for staining of 48 normal human tissue samples as well as human cancer samples covering the 20 most common cancer types and up to 12 patients for each cancer type.
Gene ID: 8289
Swiss prot ID: O14497
Related products: 
Related products: Corresponding Atlas Antigen: APrEST70748
Additional information: 
Synonyms: HPA005456; ARID1A / BAF250; ARID1A; hOSA1; hELD; SMARCF1; P270; OSA1; MRD14; ELD; C1orf4; BM029; BAF250a; BAF250; B120; osa homolog 1; chromatin remodeling factor p250; brain protein 120; SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin subfamily F member 1; SWI/SNF complex protein p270; SWI-like protein; OSA1 nuclear protein; BRG1-associated factor 250a; AT-rich interactive domain-containing protein 1A; ARID domain-containing protein 1A; AT rich interactive domain 1A (SWI-like)
Yamamoto S, Tsuda H, Takano M, Tamai S, Matsubara O. "PIK3CA mutations and loss of ARID1A protein expression are early events in the development of cystic ovarian clear cell adenocarcinoma.". Virchows Arch 2012 Jan; 460(1):77-87. Epub 2011 Nov 26. DOI: 10.1007/s00428-011-1169-8. Read more
Wang K, Kan J, Yuen ST, Shi ST, Chu KM, Law S, Chan TL, Kan Z, Chan AS, Tsui WY, Lee SP, Ho SL, Chan AK, Cheng GH, Roberts PC, Rejto PA, Gibson NW, Pocalyko DJ, Mao M, Xu J, Leung SY. "Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer.". Nat Genet 2011 Oct 30; 43(12):1219-23. Epub 2011 Oct 30. DOI: 10.1038/ng.982. Read more
Yamamoto S, Tsuda H, Takano M, Tamai S, Matsubara O. "Loss of ARID1A protein expression occurs as an early event in ovarian clear-cell carcinoma development and frequently coexists with PIK3CA mutations.". Mod Pathol 2012 Apr; 25(4):615-24. Epub 2011 Dec 9. DOI: 10.1038/modpathol.2011.189. Read more
Guan B, Mao TL, Panuganti PK, Kuhn E, Kurman RJ, Maeda D, Chen E, Jeng YM, Wang TL, Shih IM. "Mutation and loss of expression of ARID1A in uterine low-grade endometrioid carcinoma". Am J Surg Pathol 2011 May; 35(5):625-632. DOI: 10.1097/PAS.0b013e318212782a. Read more
Wu CH, Mao TL, Vang R, Ayhan A, Wang TL, Kurman RJ, Shih IM. "Endocervical-type Mucinous Borderline Tumors are Related to Endometrioid Tumors Based on Mutation and Loss of Expression of ARID1A". Int J Gynecol Pathol 2012 Jul; 31(4):297-303. DOI: 10.1097/PGP.0b013e31823f8482. Read more
Rahmanto YS, Jung JG, Wu RC, Kobayashi Y, Heaphy CM, Meeker AK, Wang TL, Shih IM. "Inactivating ARID1A Tumor Suppressor Enhances TERT Transcription and Maintains Telomere Length in Cancer Cells". J Biol Chem 2016 Mar 7; 291(18):9690-9699. Epub 2016 Mar 7. DOI: 10.1074/jbc.M115.707612. Read more